Lumida
/DCO
⌘K
Ducommun Inc

Ducommun Inc

DCO
$172.73USD+3.34%+5.59 today

MARKET CAP

2.6B

P/E (TTM)

FWD P/E

DAY RANGE

$167 – $173

52W RANGE

$85
$210

AI Summary

Stalk
TrimMedium

DCO is in a Stage 4 decline after a decisive break below the EMA9/20 and SMA50, activating mean-reversion patterns and tilting the medium-term bias bearish. Price is oversold near the $165–$160 support zone but lacks a confirmed bullish reversal or RSI divergence. The preferred approach is to trim into rallies up into the EMA9/20/SMA50 cluster around $174–$182 for rejection. A failure below $165 would signal deeper mean reversion toward $150–$140.

  • Q2 revenue reached $224.5M, marking 5th straight quarter above $200M
  • Missile portfolio grew 68% in Q2, driven by PAC-3 contract ramps
  • Negative earnings yield and weak profitability factors deter investors
Full analysis →

Buying

9

institutions

Selling

4

institutions

New Positions

5

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY1.94 M359.40 M+171.25 K+66.5%0.01%
MC

Moore Capital Management, LP

Q2 2026

BUYNEW238.84 K44.24 M+238.84 K+0.0%0.67%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW94.15 K17.44 M+94.15 K+0.0%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW55.98 K10.37 M+55.98 K+0.0%0.01%
AC

Aqr Capital Management LLC

Q2 2026

SELL46.35 K8.59 M+-1.58 K+46.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY42.82 K7.93 M+42.82 K+1083378.6%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY19.79 K3.66 M+12.22 K+297.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL11.01 K2.03 M+-26.70 K-54.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW10.72 K1.98 M+10.72 K+0.0%0.02%
RT

Renaissance Technologies LLC

Q2 2026

SELL10.70 K1.98 M+-36.50 K-65.6%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY12.02 K1.47 M+6.01 K+155.4%0.00%
MM

Millennium Management LLC

Q2 2026

SELL6.88 K1.27 M+-101.71 K-90.4%0.00%
BA

Bridgewater Associates, LP

Q2 2026

BUYNEW5.08 K939.94 K+5.08 K+0.0%0.00%